Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Single Center, Pilot Study of Siltuximab, an Anti-IL6 Therapy, for Patients With Myelofibrosis

NCT02805868 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02805868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02805868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Single Center, Pilot Study of Siltuximab, an Anti-IL6 Therapy, for Patients With Myelofibrosis
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Withdrawn
Start date
June 30, 2016
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis, polycythemia vera, primary myelofibrosis, thrombocytopenia